Ro-44-3888
![]() | |
| Identifiers | |
|---|---|
| PubChem | CID 9907685 |
| ChemSpider | 8083337 |
| ChEMBL | CHEMBL65267 |
| Chemical data | |
| Formula | C18H24N4O5 |
| Molar mass | 376.4 g/mol |
| |
| |
Ro 44-3888 is a non-peptidic, selective and reversible glycoprotein IIb/IIIa inhibitor. It is the active metabolite of sibrafiban. It was being investigated as a treatment for heart conditions, including myocardial infarctions. The development of Ro 44-3888 and sibrafiban was discontinued in 1999 following unfavorable Phase III efficacy data.
See also
| ||||||||||||||||||||||||||||||||||||||||||
This article is issued from Wikipedia - version of the Saturday, April 02, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.
